Refine by
Gastroesophageal Suppliers & Manufacturers
11 companies found
based inJavene, FRANCE
HTL is a leading biotech and industrial player in the development and production of innovative, pharmaceutical-grade biopolymers that are used by leading pharmaceutical and medical device companies to transform the lives of millions of patients in ...
HTL is offering a new source of Chondroitin Sulfate and other derivatives, of non-animal origin. While most Chondroitin Sulfate on the market is of animal origin (bovine, pig, shark, fish, bird), HTL is developing a new source of Chondroitin Sulfate ...
based inRedmond, WASHINGTON (USA)
EndoGastric Solutions, Inc., is a leader in incisionless procedural therapy for GERD. EGS’ mission is to combine the most advanced concepts in gastroenterology and surgery to develop products and procedures that address unmet needs in ...
While clinical studies support the effectiveness of TIF (Transoral Incisionless Fundoplication) in treating chronic GERD (gastroesophageal reflux disease), individual results may vary. There are no guarantees of successful outcome. ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
PNU-159682, a metabolite of the anthracycline Nemorubicin, is a highly potent DNA topoisomerase II inhibitor with excellent cytotoxicity. PNU-159682 acts as a more potent and tolerated ADC cytotoxin than Doxorubicin for ADC synthesis. PNU-159682 can ...
based inPescantina (VR), ITALY
We initiate and implement projects for human health. Our products are the result of many years of research and development, experience in the field of plant biochemistry and other natural components. We examine medicinal and endemic plants from all ...
ESOMER is a drug, which due to a specific mechanism of action reduces the intensity of acid secretion in the ...
based inBrussels, BELGIUM
PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments. The company is advancing its lead product ...
Our lead product candidate, CAM-H2, consists of an HER2-targeting single-domain antibody linked to iodine-131. This targeted radioligand therapy is being developed for the treatment of patients with metastatic HER2-positive cancer indications, such ...
based inMilwaukee, WISCONSIN (USA)
At Diversatek Healthcare, we believe our role is to serve you so you can provide exceptional patient care. That’s why we strive to equip you with the technologically advanced scientific innovations and workflow solutions, and offer a comprehensive ...
based inBeirut, LEBANON
Innovative Medical Solutions is a frontline provider of innovative medical technology that caters to all fields of contemporary medical practice. Our goal is to answer the most pressing questions in the field of medicine today through sourcing ...
The Stretta Procedure is an endoscopically-guided, minimally invasive, outpatient procedure performed by an endoscopist in approximately 60 minutes. The Stretta Catheter, powered by the Stretta Control Module, is an innovative design for simple, ...
based inTokyo, JAPAN
Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in 29 countries/regions around the world. With more than 120 years of scientific expertise, our company draws upon a rich ...
ENHERTU (5.4 mg/kg) is approved in more than 50 countries for the treatment of adult patients with unresectable or metastatic HER2 positive breast cancer who have received a (or one or more) prior antiHER2-based regimen, either in the metastatic ...
based inGhaziabad, INDIA
Myra & Co., a professionally managed & equipped organization, came into existence in the spring of 2011 with a clear vision & commitment of leveraging its domain expertise to meet the needs of modern-day healthcare through the harmonization of ...
FusionKraft range of preferred Cardio-Thoracic & Vascular Surgical Instruments is a comprehensive selection of specialized surgical essentials dealing into the management of the ailments of the organs inside the Thorax (the chest) – ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of ...
Zanidatamab is currently being evaluated in global Phase 1, Phase 2 and pivotal clinical trials as a best-in-class treatment for patients with HER2-expressing cancers, including biliary tract, gastroesophageal adenocarcinomas, ...
based inMelbourne, AUSTRALIA
Starpharma Holdings Limited is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP drug delivery and ...
DEP® cabazitaxel is an enhanced version of leading prostate cancer drug cabazitaxel (Jevtana®). Cabazitaxel (Jevtana®) had global sales of €536M in 2020 despite having multiple US FDA “Black Box” warnings. ...